Selective effect of thiazides on the human osteoblast-like cell line MG-63

Kidney International

Volumn 50, Issue 5, 1996, Pages 1476-1482

  Aubin, R ^a   Menard P ^a   Lajeunesse, Daniel ^a,b  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CHLOROTHIAZIDE; CYCLOTHIAZIDE; DIAZOXIDE; HYDROCHLOROTHIAZIDE; OSTEOCALCIN; THIAZIDE DIURETIC AGENT;

ARTICLE; BONE DENSITY; CELL LINE; HUMAN; HUMAN CELL; OSTEOBLAST; PRIORITY JOURNAL;

EID: 0029949133     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.461     Document Type: Article

References (43)

1. ODLIND B, LONNERHOLM G: Renal tubular secretion and effects of chlorothiazide, hydrochlorothiazide and clopamide: A study in the avian kidney. Acta Pharmacol Toxicol 51:187-197, 1982
2. DAN T, GEMBA M: Effects of diuretics on calcium uptake and release in renal microsomes. Biochem Pharmacol 29:2339-2343, 1980
3. COSTANZO LS, WINDHAGER EE: Calcium and sodium transport by the distal convoluted tubule of the rat. Am J Physiol 235:F492-F506, 1978
4. COSTANZO LS: Localization of diuretic action in microperfused rat distal tubules: Ca and Na transport. Am J Physiol 17:F527-F535, 1985
5. 3H]metalozone. Proc Natl Acad Sci USA 85:2311-2314, 1988
6. 3H]Metolazone. J Pharmacol Exp Ther 250:414-419, 1989
7. BRUNETTE MG, HARVEY N, MAILLOUX J, BOUHTIAUY I, LAJEUNESSE D: The hypocalciuric effect of thiazides: study of the mechanisms, in Proceedings of the Third International Conference on Diuretics. Diuretics III. Chemistry, Pharmacology and Clinical Applications, edited by PUSCHETT JB, GREENBERG A, New York, Elsevier Science Publishing Co., 1989, pp 225-227
8. LAJEUNESSE D, BRUNETTE MG: The hypocalciuric effect of thiazides: Subcellular localization of the action. Pflügers Arch 417:454-462, 1991
9. COE FL, PARKS JH, BUSHINSHY DA, LANGMAN DB, FAVUS MJ: Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria. Kidney Int 33:1140-1146, 1988
10. WASNICH RD, BENFANTE RJ, YANO K, HEILBRUN L, VOGEL JM: Thiazide effect on the mineral content of bone. N Engl J Med 309:344-347, 1983
11. WASNICH RD, Ross PD, HEILBRUN LK, VOGEL JM, YANO K, BENFANTE RJ: Differential effects of thiazide and estrogen upon bone mineral content and fracture prevalence. Obstetrics Gynecol 67:457-462, 1986
12. CAULEY JA, CUMMINGS SR: Thiazide diuretics preserve bone mass and reduce the risk of fractures in elderly women: A prospective study. (abstract) J Bone Miner Res 4(Suppl 1):216, 1989
13. RAY WA, GRIFIN MR, DOWNEY W, MELTON LJ: Long-term use of thiazide diuretics and risk of hip fracture. Lancet 1:687-690, 1989
14. ADLAND-DAVENPORT P, MCKENZIE MW, NOLELOFITZ M, MCKENZIE LC, PENDERGAST JF: Thiazide diuretics and bone mineral content in postmenopausal women. Am J Obstet Gynecol 152:630-634, 1985
15. WASNICH RD, DAVIS JW, Ross PD, VOGEL JM: Thiazides reduce bone loss rate among men. A longitudinal study. (abstract) J Bone Miner Res 5(Suppl 1):157, 1990
16. LACROIX AZ, WIENPAHL J, WHITE LR, WALLACE RB, SCHERR PA, GEORGE LK, CORNONI-HUNTLEY J, OSTFELD AM: Thiazide diuretic agents and the incidence of hip fracture. N Engl J Med 322:286-290, 1990
17. LEMANN J JR, GRAY RW, MAIERHOFER WJ, CHEUNG HS: Hydrochlorothiazide inhibits bone resorption in men despite experimentally elevated serum 1,25-dihydroxyvitamin D concentrations. Kidney Int 28:951-958, 1985
18. JONES G, NGUYEN T, SAMBROOK PN, EISMAN JA: Thiazide diuretics and fractures: Can meta-analysis help? J Bone Miner Res 10:106-111, 1995
19. LAJEUNESSE D, FRONDOZA C, SCHOFFIELD B, SACKTOR B: Osteocalcin secretion by the human osteosarcoma cell line MG-63. J Bone Miner Res 5:915-922, 1990
20. PUZAS JE, BRAND JS: The effect of bone cell stimulatory factors can be measured with thymidine incorporation only under specific conditions. Calcif Tissue Int 39:104-108, 1986
21. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275, 1951
22. LAJEUNESSE D, KIEBZAK GM, FRONDOZA C, SACKTOR B: Regulation of osteocalcin secretion by human primary bone cells and by the human osteosarcoma cell line MG-63. Bone Miner 14:237-250, 1991
23. HALL TJ, SCHAUEBLIN M: Hydrochlorothiazide inhibits osteoclastic bone resorption in vitro. Calcif Tissue Int 55:266-268, 1994
24. SONG X, WERGEDAL JE: Hydrochlorothiazide stimulates proliferation of human osteoblasts in vitro (abstract). J Bone Miner Res 8:S362, 1993
25. SAKHAEE K, NICAR MJ, GLASS K, ZERWEKH JE, PAK CYC: Reduction in intestinal calcium absorption by hydrochlorothiazide in postmenopausal osteoporosis. J Clin Endocrinol Metab 59:1037-1043, 1984
26. 2-vitamin D in postmenopausal osteoporosis. Osteoporosis Int 3:209-214, 1993
27. PEH CA, HOROWITZ M, WISHART JM, NEED AG, MORRIS HA, NORDIN BEC: The effect of chlorothiazide on bone-related biochemical variables in normal post-menopausal women. J Amer Geriatric Soc 41:513-516, 1993
28. HAUSCHKA PV, LIAN JB, COLE DEC, GUNDBERG CM: Osteocalcin and matrix Gla protein: Vitamin K-dependent proteins in bone. (Review) Physiol Rev 69:990-1047, 1989
29. BEERMANN B, GROSCHINSKY-GRIND M: Antihypertensive effect of various doses of hydrochlorothiazide and its relation to the plasma level of the drug. Eur J Clin Pharmacol 13:195-201, 1978
30. STANLEY ER: Action of the colony-stimulating factor, CSF-1, in Biochemistry of Macrophages (vol 118), New York, Ciba Foundation Symposium, Wiley J & Sons, 1986, pp 29-41
31. BEYER KH JR, BAER JE: The site and mode of action of some sulfonamide-derived diuretics. Med Clin N Am 59:735-750, 1975
32. MAREN TH, SANYAL G: A simplified micromethod for the determination of carbonic anhydrase and its inhibitors. J Pharm Exp Ther 130:266-269, 1960
33. MOORE PF: The effects of diazoxide and benzothiadiazine diuretics upon phosphodiesterase. Ann NY Acad Sci 150:256-260, 1968
34. SENFT G, LOSERT W, SCHULTZ G, SITT R, BARTELHEIMER HK: Ursachen der Störungen im Kohlenhydratstoffwechsel unter dem Einfluss sulfonamidierter Diuretica. Arch Exp Pathol Pharmakol 255: 369-382, 1966
35. KHAN SR, HACKETT RL: Calcium oxalate urolithiasis in the rat: Is it a model for human stone disease? A review of recent literature. Scanning EM II:759-774, 1985
36. MCKEE MD, NANCI A, KHAN SR: Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of urinary calculi. (abstract) J Bone Miner Res 9(Suppl 1):C190, 1994
37. NEMIR M, DEVOUGE MW, MUKHERJEE BB: Normal rat kidney cells secrete both phosphorylated and nonphosphorylated forms of osteopontin showing different physiological properties. J Biol Chem 264:18202-18208, 1989
38. RITTER NM, FARACH-CARSON MC, BUTLER WT: Evidence for the formation of a complex between osteopontin and osteocalcin. J Bone Miner Res 7:877-885, 1992
39. RUMLL LA, DUBOIS SK, ROBERTS ML, PAK CYC: The effect of alendronate on immobilization-induced bone loss and stone-forming propensity. (abstract) J Bone Miner Res 9(Suppl 1):B155, 1994
40. 3-induced increase of osteocalcin in plasma of rats in vivo and in culture medium of rat calvaria in vitro. Calcif Tissue Int 42:248-254, 1988
41. PERRY HM III DAYS, JENSEN J, KAISER FE, HOROWITZ M, PERRY HM JR, MORLEY JE: The effects of thiazide diuretics on calcium metabolism in the aged. J Am Geriatrics Soc 41:818-822, 1993
42. DAWSON-HUGHES B, HARRIS S: Thiazides and seasonal bone change in healthy postmenopausal women. Bone Miner 21:41-51, 1993
43. GHAZALI A, BATAILLE P, FUENTES V, PRIN L, COHEN SOLAL ME, EL ESPER N, HUÉ P, FOURNIER A: Role of monokines in bone demineralization of calcium stone formers with idiopathic hypercalciuria. (abstract) J Bone Miner Res 9(Suppl 1):B468, 1994